Vaccination against schistosomiasis infection is under development
Release date: 2015-10-23 Image source: imperialighi.wordpress.com More than 200 million people in 74 countries around the world suffer from schistosomiasis, and many of them are four times more likely to get sick because of the inability to obtain pure water. The latest one from Texas Tech University Research may help reduce the number of people with schistosomiasis. Researcher Professor Afzal A. Siddiqui said that we have tested a new vaccine against schistosomiasis in animals. The vaccine is currently planned for human clinical trials, and the new schistosomiasis vaccine has been awarded by the US Patent and Trademark Office. Patent. The vaccine, called SchistoShield, could potentially affect the health of at least 1 billion people, and researchers say they are trying to develop the vaccine in hopes of dispelling the idea of ​​those who use the vaccine as a means of profit. It is charged at $1 per vaccination and is being provided to the people who need it. Praziquantel, a drug developed 40 years ago, is the only drug that can treat schistosomiasis, but patients may experience reinfection, so developing a potential vaccine may be a wise choice. According to World Health Organization data, there is currently no commercial vaccine to help fight schistosomiasis, and symptoms of schistosomiasis can lead to sexually transmitted diseases, such as increased risk of HIV infection. The schistosomiasis vaccine can provide scientists with a new strategy to completely eliminate the disease, but also to prevent the patient from re-infection. Individuals often suffer from schistosomiasis by drinking contaminated water. Parasites can reproduce in the body of the patient, and then lurk into the body and migrate to the lungs and liver for maturation. Researcher Siddiqui said that the main pathological manifestations of schistosomiasis Depending on the patient's immune response to the schistosomiasis in the tissue, persistent infection can cause the liver to become larger and the blood in the urine to appear. Although current schistosomiasis patients can already use drugs for group treatment, the infection rate remains high. There are still 800 million people worldwide who are exposed to schistosomiasis infections. The lasting and stable way to reduce infection seems to be through vaccination. Maintain, and the researchers in this article have developed this new type of schistosomiasis vaccine, which may help humans effectively inhibit the occurrence of schistosomiasis. Source: Bio Valley Qingdao Beautiful Skin Biotechnology Co., Ltd , https://www.hafilleresthetic.com